Screener
Supernus Pharmaceuticals SUPN Market capitalization
Market capitalization at other companies
Other financials
Where this comes from
Computed from the period-end share price: $2.98B.
The source filing: Supernus Pharmaceuticals’s 10-Q, filed May 5, 2026. Open the filing →
- Filed
- May 5, 2026, 4:15 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001356576-26-000022
FAQ
- What is Supernus Pharmaceuticals's market capitalization?
- Supernus Pharmaceuticals (SUPN) reported market capitalization of $2.98B in Q1 2026.
- How has Supernus Pharmaceuticals's market capitalization changed year-over-year?
- Supernus Pharmaceuticals's market capitalization increased by 62.8% year-over-year, from $1.83B to $2.98B.
- What is the long-term trend for Supernus Pharmaceuticals's market capitalization?
- Over 5 years (2020 to 2025), Supernus Pharmaceuticals's market capitalization has grown at a 16.4% compound annual growth rate (CAGR), from $1.33B to $2.85B.
- What does market capitalization mean?
- The total market value of the company's equity at the quarter end (share price × shares outstanding), sampled from daily market data. The latest point tracks the live price.
Ask your AI about Supernus Pharmaceuticals's market capitalization.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude